Source: Annual Congress 2004 - Lung fibrosis sarcoidosis alveolar microlithiasis and proteinosis
Disease area: Interstitial lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
T. Tachibana, T. Johkoh, H. Sumikawa, S. Abe, S. Nakajima, T. Ishida (Osaka, Sapporo, Nara, Kurasiki, Japan). Clinical characteristics of pulmonary alveolar microlithiasis in Japan. Eur Respir J 2004; 24: Suppl. 48, 4087

Member's Comments

No comment yet.

Related content which might interest you: Long clinical course of pulmonary alveolar microlithiasis in Japan Source: Eur Respir J 2003; 22: Suppl. 45, 198s Year: 2003 Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan Source: Eur Respir J 2011; 37: 465 Year: 2011 Pulmonary alveolar microlithiasis Source: International Congress 2019 – Insights into paediatric bronchology Year: 2019 Pulmonary alveolar microlithiasis Source: Eur Respir Rev, 29 (158) 200024; 10.1183/16000617.0024-2020 Year: 2020 Pulmonary alveolar microlithiasis (PAM) Source: Eur Respir J 2001; 18: Suppl. 33, 220s Year: 2001 Clinical and paraclinical manifestations of pulmonary alveolar proteinosis in children Source: Eur Respir J 2007; 30: Suppl. 51, 402s Year: 2007 New mutation associated to the pulmonary alveolar microlithiasis Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010 Clinical assessment and management of pulmonary alveolar proteinosis: the importance of a reference centre Source: Annual Congress 2009 - Pulmonary alveolar proteinosis: clearing the Milky Way Year: 2009 Pulmonary alveolar microlithiasis: case report Source: Eur Respir J 2004; 24: Suppl. 48, 670s Year: 2004 Pulmonary alveolar microlithiasis: a case report Source: Eur Respir J 2004; 24: Suppl. 48, 489s Year: 2004 Lung cysts in pulmonary alveolar proteinosis. Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018 Pulmonary alveolar proteinosis: from classification to therapy Source: Breathe, 16 (2) 200018; 10.1183/20734735.0018-2020 Year: 2020 Fatal cases of pulmonary alveolar proteinosis: a nationwide surveillance in Japan Source: International Congress 2018 – Progress in rare interstitial lung diseases Year: 2018 Pulmonary alveolar microlithiasis: no longer in the stone age Source: ERJ Open Res, 6 (3) 00289-2020; 10.1183/23120541.00289-2020 Year: 2020 Clinical features of four children with pulmonary alveolar proteinosis Source: International Congress 2014 – ILDs 5 Year: 2014 First presentation of a case of pulmonary alveolar microlithiasis with spontaneous pneumothorax Source: Annual Congress 2012 - The good clinical practice: useful case report Year: 2012 Pulmonary alveolar proteinosis and idiopathic pulmonary hemosiderosis Source: International Congress 2019 – CCC Airway diseases Year: 2019 Clinical characteristics of surgically-diagnosed pulmonary cryptococcosis Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies Year: 2011 Pulmonary alveolar proteinosis (PAP) - clinical features and response to treatment by bronchofiberoscopic lobar lavage Source: Eur Respir J 2005; 26: Suppl. 49, 541s Year: 2005